Recall Register

Food, drugs, devices › B-K Medical A/S

Device recall: 1202 Flex Focus Ultrasound System, cart models UA1214 and UA1814, used with: Flex Focus 200, Flex Focus 300, Flex Focus

FDA enforcement event 97830 · Class II · initiated 9 Oct 2025 · status Ongoing

DeviceVoluntary: Firm initiated6 product recordsHerlev, N/A

B-K Medical A/S (Herlev, N/A) initiated this device recall on 9 Oct 2025; FDA lists 6 product records under event 97830, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 85% of the 945 device enforcement events initiated in 2025 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. B-K Medical A/S has 4 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

B-K Medical A/S, Herlev, N/A, Denmark.

Reason for recall

"GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions."

Distribution

"Worldwide distribution: US (nationwide) and OUS (foreign) to countries of: Algeria, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0435-20261202 Flex Focus Ultrasound System, cart models UA1214 and UA1814, used with: Flex Focus 200, Flex Focus 300, Flex Focus 400, Flex Focus 500, Flex Focus 700, Flex Focus 800; System, Imaging, Pulsed Doppler, Ultrasonic4426 unitsClass IIOngoing12 Nov 2025
Z-0436-2026Ultrasound System 1300, bkSpecto w/battery; Model No. 1300-21 or 1300-S1; System, Imaging, Pulsed Doppler, Ultrasonic1697 unitsClass IIOngoing12 Nov 2025
Z-0437-2026UUltrasound System 2300, bkActiv w/battery; Model No. 2300-11; System, Imaging, Pulsed Doppler, Ultrasonic567 unitsClass IIOngoing12 Nov 2025
Z-0438-2026bk3000 Ultrasound System w/battery; Model No. 2300-66; System, Imaging, Pulsed Doppler, Ultrasonic496 unitsClass IIOngoing12 Nov 2025
Z-0439-2026bk3500 Ultrasound System w/battery; Model No. 2300-41; System, Imaging, Pulsed Doppler, Ultrasonic124 unitsClass IIOngoing12 Nov 2025
Z-0440-2026bk5000 Ultrasound System w/battery; Model No. 2300-61; System, Imaging, Pulsed Doppler, Ultrasonic895 unitsClass IIOngoing12 Nov 2025

Context

85%of 2025 device events are Class II945 events that year
6product records in this eventfirm median: 1
4events on this register for the firm

Other enforcement events for B-K Medical A/S

InitiatedProduct (first record)TypeClassRecords
4 Sep 2024bk3000, model #2300-11; bk3500, model #2300-41; bk5000, model #2300-61; and bkActive 2300, model #2300-66, ultrasound syDeviceClass II1
30 Nov 2023bkActiv Ultrasound System 2300, Model numbers 2300-56 and 2300-66.DeviceClass II1
28 Jun 2016BK Medical ApS Ultrasound System Scanner bk2300 - Model #: bk3500 with software releases 1.2.0, 1.2.1 and 1.2.2. The sysDeviceClass II1

All 4 events for B-K Medical A/S

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution: US (nationwide) and OUS (foreign) to countries of: Algeria, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia,…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.